World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF).
Earlier this year, TTG Transportation Technology was sold to Toronto-based technology company, Modaxo, which specialises in global public ...
Read more
Supporting the commercialisation of UniSA software research.
Read more
2020 is off to a strong start for UniSA Ventures, with four new technologies added to our portfolio ...
Read more
A new $45 million investment fund has been launched to accelerate the development and commercialisation of health and ...
Read more
UniSA Ventures spin-out biotech company Ferronova has completed the first batch of manufacturing at UniSA’s state of the ...
Read more
Professors from UniSA will work together with GSK scientists to test GSK compound libraries against a target protein ...
Read more
Myriota today announced that former NASA astronaut and ex-DARPA Deputy Director of the Tactical Technology Office, Pamela Melroy, ...
Read more
Companies form partnership to support manufacture of over 12,000 massive mirror assemblies in South Australia for the Aurora ...
Read moreSome of these cookies are essential for the website to function correctly, while others may collect your personal information. In some cases, the personal information collected by our cookies may be shared with third party service providers.
For details about the categories of cookies that we use, and to set your cookie preferences, please select ‘More information’ before you continue. For an overview see our Privacy Statement, or review our Privacy Policy in full.